Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine and sacroiliac joints, typically beginning in young adulthood. Estimates vary, but roughly 1 in 100 to 1 in 200 American adults meet criteria for AS or the closely related non-radiographic axial spondyloarthritis, according to the Spondylitis Association of America. The disease is famously underrecognized — average time from symptom onset to diagnosis has historically run many years — partly because back pain is common and inflammatory back pain is poorly distinguished from mechanical pain in primary care. This guide explains what to look for, how doctors diagnose it, and how it is treated today. It is educational and does not replace evaluation and care from a rheumatologist.
Inflammatory Back Pain: The Key Clue
Most back pain is mechanical — worse with activity, better with rest, no significant morning stiffness. Inflammatory back pain runs the opposite pattern. Onset before age 45, gradual development over months, morning stiffness lasting more than 30 minutes, improvement with movement, alternating buttock pain (suggesting sacroiliitis), and night pain that wakes patients in the second half of the night are classic features.
Rheumatology classification criteria treat back pain as inflammatory when several of these features are present together. This pattern in a young adult should trigger evaluation for spondyloarthritis rather than treatment for presumed mechanical strain. The NIAMS emphasizes that AS often begins in the late teens or twenties and can progress for years before diagnosis. If your back pain feels worse after resting and eases once you start moving, that is worth mentioning specifically to your clinician — it is the opposite of what most people expect from a “bad back.”
Beyond the Spine
AS is part of the spondyloarthritis family and shares features with psoriatic arthritis, reactive arthritis, and IBD-associated arthritis. Peripheral joint involvement — usually large joints, asymmetric — affects a substantial minority of patients. Enthesitis, inflammation where tendons and ligaments attach to bone, is common at sites like the Achilles tendon and the plantar fascia of the heel.
Acute anterior uveitis affects a meaningful share of AS patients (often cited around 30 to 40 percent over the disease course) and presents as a painful, red, light-sensitive eye that requires urgent ophthalmology evaluation. Inflammatory bowel disease (Crohn’s or ulcerative colitis) affects a smaller percentage. Less common but important associations include aortic root inflammation, cardiac conduction abnormalities, restrictive lung changes from chest wall involvement, and osteoporosis with vertebral fractures. Skin psoriasis can also accompany the disease. Because the condition reaches beyond the spine, care often involves more than one specialist.
Genetics and HLA-B27
HLA-B27, an MHC class I gene, is found in a large majority of AS patients but only a small percentage of the general US population. Despite this strong association, having HLA-B27 alone does not guarantee disease — only a minority of HLA-B27-positive individuals ever develop AS. The gene is more useful as supporting evidence in someone with suggestive symptoms than as a screening test in healthy people, which is why doctors do not use it to screen the general population.
Family history meaningfully raises risk. First-degree relatives of AS patients have several times the population risk. The disease has traditionally been considered more common and more severe in men, though under-diagnosis in women is increasingly recognized — women may present with more neck and peripheral symptoms and are sometimes misdiagnosed with fibromyalgia or mechanical pain.
Diagnosis
Modern classification of axial spondyloarthritis is based on imaging or HLA-B27 combined with clinical features. Active inflammation on MRI of the sacroiliac joints — bone marrow edema — can establish axial disease before X-ray changes appear. When inflammation is present on MRI but plain X-rays are still normal, the condition is called non-radiographic axial spondyloarthritis (nr-axSpA); some, but not all, patients with nr-axSpA later progress to radiographic AS.
X-ray changes — sacroiliitis, vertebral squaring, syndesmophytes (bony bridges between vertebrae), and ultimately the “bamboo spine” of advanced disease — develop over years. Modern practice does not wait for X-ray findings to start treatment; that delay was responsible for much of the historical disability associated with AS.
Bloodwork shows elevated CRP and ESR in many but not all patients with active disease, so normal inflammatory markers do not rule the condition out. HLA-B27 testing supports the diagnosis when it fits the imaging and clinical picture. Consistent with guidance summarized by sources such as MedlinePlus and the Cleveland Clinic, MRI sacroiliitis combined with at least one clinical feature can classify axial spondyloarthritis even in HLA-B27-negative patients. Rheumatoid factor and anti-CCP antibodies are typically negative, which helps distinguish AS from rheumatoid arthritis.
Treatment
Note: the medications below are prescriber-directed. This section names drug classes and examples for understanding only and does not include doses or schedules. Never start, stop, or change a prescription without your clinician.
NSAIDs are first-line and remain effective for many patients. Continuous NSAID use may help symptoms and, in some patients with high inflammatory markers, has been studied for its effect on radiographic progression, though gastrointestinal, kidney, and cardiovascular risks limit long-term high-dose use. Common NSAID choices your doctor may consider include naproxen, ibuprofen, indomethacin, and celecoxib — the specific drug and dose are decisions for your prescriber.
For patients with persistent symptoms despite optimal NSAIDs, biologics transform outcomes. TNF inhibitors (adalimumab, etanercept, infliximab, golimumab, and certolizumab pegol) and IL-17 inhibitors (secukinumab, ixekizumab, and the newer bimekizumab) are FDA-approved for AS; several are also approved for non-radiographic axial spondyloarthritis. According to the Spondylitis Association of America, these agents carry warnings about serious infections (including reactivation of tuberculosis, so TB testing is done before starting), and IL-17 inhibitors can worsen inflammatory bowel disease in some patients.
JAK inhibitors (upadacitinib and tofacitinib) are oral options approved for AS when biologics are not suitable or effective. This drug class carries an FDA boxed warning — the agency’s strongest — for serious infections, major adverse cardiovascular events, blood clots, cancer, and death, based on data from a rheumatoid arthritis safety study. Because of this, JAK inhibitors are generally reserved for specific situations and require a careful risk discussion with a rheumatologist.
Conventional DMARDs like methotrexate and sulfasalazine are largely ineffective for axial (spinal) disease but may help peripheral arthritis. Local steroid injections to sacroiliac joints, peripheral joints, or entheses help selected patients. Choosing among these options is individualized, weighing disease severity, other conditions (such as IBD, psoriasis, or recurrent uveitis), and personal risk factors.
Exercise Is Treatment
AS is one of the few rheumatic diseases where structured exercise has a clear, durable benefit. Daily flexibility exercises, posture training, deep breathing exercises to maintain chest wall expansion, and core strengthening preserve function and reduce stiffness. Hydrotherapy (pool exercise) is particularly helpful for patients with significant pain because the water reduces load on painful joints.
Yoga, swimming, and tai chi all have supporting evidence for AS. Posture awareness — frequent reminders to stand straight, sleep on a firm mattress with a thin pillow, and avoid prolonged stooped postures — helps prevent the kyphotic (forward-curved) deformity that long-untreated AS can produce. A physical therapist experienced with spondyloarthritis can tailor a program and is worth asking your rheumatologist to refer you to.
When to seek emergency care: Call 911 or go to the nearest emergency room if you experience sudden severe back pain after a fall (vertebral fractures occur more easily in AS due to spinal fusion and osteoporosis), new bowel or bladder dysfunction, sudden severe leg weakness or numbness, sudden severe eye pain with redness and vision changes (possible acute uveitis, which needs same-day eye care), severe chest pain, or signs of serious infection while on immunosuppressants. Vertebral fractures in fused spines can cause spinal cord injury and require immediate evaluation.
Long-Term Concerns
Cardiovascular disease risk is elevated, similar to other inflammatory arthritides, so managing blood pressure, cholesterol, and other heart risk factors matters. Aortitis and conduction blocks, while uncommon, do occur. Restrictive lung changes from a rigid chest wall can reduce vital capacity in advanced disease, and apical pulmonary fibrosis is rare but classic.
Osteoporosis can develop paradoxically alongside the new bone formation in the spine. Vertebral fractures in AS can be missed because the spine is rigid and pain is often attributed to disease activity rather than fracture; bone density (DEXA) testing is appropriate periodically. Because AS raises fracture risk, be cautious with high-impact activities and falls.
Pregnancy in AS is generally well-tolerated, though a portion of patients flare postpartum. Decisions about continuing biologics during pregnancy are individualized; certolizumab pegol has minimal placental transfer and is often discussed in this context. Any medication changes around pregnancy should be planned in advance with both a rheumatologist and an obstetric provider. Our medical conditions overview touches on chronic disease management across life stages.
When to See a Doctor
Young adults with persistent back pain — especially with morning stiffness, improvement with movement, alternating buttock pain, or a family history of spondyloarthritis or psoriasis — should be evaluated. Primary care physicians can initiate the workup with HLA-B27 testing and inflammatory markers; a rheumatology referral is appropriate for suspected disease and is the right home for ongoing management.
Established AS patients need regular rheumatology follow-up, prompt ophthalmology care when uveitis symptoms appear, and primary care for cardiovascular risk and bone health. Given the multiple specialty needs, keeping up with dental and vision care and coordinating your providers helps. Comparing this disease with related axial conditions in our psoriatic arthritis guide can help patients understand the broader spondyloarthritis family.
Frequently Asked Questions
Is ankylosing spondylitis a disability?
It can be, but most patients with modern treatment maintain employment and daily function. Severe untreated disease leading to spinal fusion can produce significant disability. Earlier treatment, including biologics when needed, has substantially reduced rates of severe disability compared to historical outcomes.
Can ankylosing spondylitis be cured?
There is no cure, but effective treatment can produce sustained low disease activity or remission and slow or halt progression. Many patients on biologics do well for years. Established bony fusion is permanent, which is why early treatment matters.
What is the life expectancy with ankylosing spondylitis?
Life expectancy is modestly reduced in older studies — primarily due to cardiovascular disease and complications of advanced disease. Modern treatment likely narrows this gap, though long-term data on biologic-treated cohorts are still maturing. Controlling inflammation and heart risk factors is the practical takeaway.
Does cracking your back help with AS?
No. Self-manipulation provides only brief relief and does not improve the underlying inflammation. Aggressive chiropractic manipulation can be dangerous in advanced AS due to vertebral fragility and fracture risk. Structured physical therapy and prescribed exercise are far more effective and safer.
Is ankylosing spondylitis the same as axial spondyloarthritis?
Ankylosing spondylitis is the form of axial spondyloarthritis with visible damage on X-rays. Axial spondyloarthritis is the broader term that also includes non-radiographic disease, where inflammation is present (often on MRI) but X-rays are still normal. The symptoms and early treatment overlap heavily.
What to Do Next
Anyone with chronic inflammatory-pattern back pain should be evaluated for axial spondyloarthritis. The single most consequential improvement in AS care over the past 25 years has been earlier diagnosis and earlier biologic treatment when needed. Daily exercise, posture awareness, and aggressive treatment of inflammation when active disease persists despite NSAIDs are the cornerstones of preserving long-term spinal mobility. Rheumatology follow-up plus engagement with patient communities like the Spondylitis Association tends to produce better outcomes than navigating the disease alone.
TL;DR: Ankylosing spondylitis is inflammatory arthritis of the spine that starts young and shows a telltale pattern — back pain and stiffness that are worse with rest and better with movement. Diagnosis combines the clinical picture with MRI or X-ray imaging and HLA-B27, but no single test is definitive and delays are common. Treatment moves from NSAIDs to biologics (TNF and IL-17 inhibitors, including bimekizumab) and, in select cases, JAK inhibitors, which carry a boxed warning. Daily exercise is genuinely part of treatment. There is no cure, but early care makes a large difference.
This article is for general education only and is not medical advice. It does not include medication doses or schedules on purpose. Do not start, stop, or change any treatment without a licensed clinician, and see a rheumatologist for evaluation of suspected spondyloarthritis. In an emergency, call 911.
Sources
- Spondylitis Association of America — spondylitis.org (disease overview and FDA-approved medications, including bimekizumab and JAK inhibitors)
- MedlinePlus (U.S. National Library of Medicine) — Ankylosing spondylitis (symptoms, diagnosis, treatment)
- NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) — niams.nih.gov (disease course and onset)
- American College of Rheumatology — rheumatology.org (axial spondyloarthritis treatment recommendations)